131719-86-3

Basic information

• Product Name: (R)-3-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-propionaldehyde
• Synonyms: (R)-3-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-propionaldehyde
• CAS NO: 131719-86-3
• Molecular Weight: 314.541
• Mol File: 131719-86-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (R)-3-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-propionaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-propionaldehyde(131719-86-3)
• EPA Substance Registry System: (R)-3-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-propionaldehyde(131719-86-3)

Safety Data

• Hazardous Substances Data: 131719-86-3(Hazardous Substances Data)

Upstream product

• 1156545-78-6 C₅₅H₉₆O₉Si₂ 
• 131758-35-5 C₄₄H₇₃NO₁₃Si 
• 131719-83-0 C₄₁H₆₉NO₁₂Si 
• 131719-85-2 (3E,6E)-(R)-9-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-4,8-dimethyl-5-oxo-nona-3,6-dienoic acid methyl ester 
• 131758-34-4 C₆₃H₁₀₇NO₁₃Si₂ 
• 53123-88-9 (22E,24E,26E,27E,29R,30S,31R,32R,34S,36S,38S,39S,40S,41R,50R)-40,50-dihydroxy-39-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxy-cyclohexyl]-1-methyl-ethyl]-38,41-dimethoxy-29,30,31,32,42,43-hexamethyl-60,61-dioxa-51-azatricyclohexatriaconta-22,24,26⁽⁴²⁾,27⁽⁴³⁾-tetraene-44,45,46,47,48-pentone 

Downstream Products

• 1156545-81-1 C₁₇H₃₄O₄Si 
• 152299-76-8 C₆₀H₁₀₉NO₁₁Si₃ 
• 152299-74-6 (S)-Piperidine-2-carboxylic acid (1R,2S,3S)-6-allyl-3-(tert-butyl-dimethyl-silanyloxy)-1-{(R)-2-[(1S,3R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-1-methyl-ethyl}-2-methyl-5-oxo-non-8-enyl ester 
• 152299-71-3 (S)-Piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-[(1R,2R)-3-[(1S,3R,4R)-4-(tert-butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-1-((S)-1-methyl-2-oxo-ethyl)-propyl] ester 
• 131719-87-4 (2R,3S)-1-[(1S,3R,4R)-4-(tert-Butyl-dimethyl-silanyloxy)-3-methoxy-cyclohexyl]-2-methyl-hex-5-en-3-ol 

Relevant articles and documents

Total Synthesis of rapamycin

For over 30 years, rapamycin has generated a sustained and intense interest from the scientific community as a result of its exceptional pharmacological properties and challenging structural features. In addition to its well known therapeutic value as a potent immunosuppressive agent, rapamycin and its derivatives have recently gained prominence for the treatment of a wide variety of other human malignancies. Herein we disclose full details of our extensive investigation into the synthesis of rapamycin that culminated in a new and convergent preparation featuring a macro-etherification/catechol-templating strategy for construction of the macrocyclic core of this natural product.

DEGRADATIVE STUDIES ON THE TRICARBONYL CONTAINING MACROLIDE RAPAMYCIN

The degradation of rapamycin, a tricarbonyl containing macrolide similar in structure to the potent immunosuppressant FK-506, is described.Three principal fragments are obtained in this process that should have utility in the semi-synthesis of FK-506 and